Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

LASS3 antibody (AA 1-100)

The Rabbit Polyclonal anti-LASS3 antibody has been validated for ELISA and IHC (p). It is suitable to detect LASS3 in samples from Mouse and Rat.
Catalog No. ABIN7090969

Quick Overview for LASS3 antibody (AA 1-100) (ABIN7090969)

Target

See all LASS3 (CERS3) Antibodies
LASS3 (CERS3) (Ceramide Synthase 3 (CERS3))

Reactivity

  • 19
  • 8
  • 6
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Mouse, Rat

Host

  • 21
  • 3
Rabbit

Clonality

  • 23
  • 1
Polyclonal

Conjugate

  • 10
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This LASS3 antibody is un-conjugated

Application

  • 14
  • 12
  • 2
ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Binding Specificity

    • 7
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 1-100

    Cross-Reactivity

    Mouse, Rat

    Predicted Reactivity

    Human,Dog,Sheep,Pig

    Purification

    Purified by Protein A.

    Immunogen

    KLH conjugated synthetic peptide derived from human LASS3

    Isotype

    IgG
  • Application Notes

    ELISA 1:500-1000
    IHC-P 1:200-400

    Restrictions

    For Research Use only
  • Concentration

    1 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    LASS3 (CERS3) (Ceramide Synthase 3 (CERS3))

    Alternative Name

    LASS3

    Background

    Synonyms: LAG1 longevity assurance homolog 3, CerS3, LAG1 homolog, ceramide synthase 3, LASS 3, MGC 27091, CERS3_HUMAN.

    Background: May be involved in sphingolipid synthesis or its regulation

    Gene ID

    204219

    UniProt

    Q8IU89
You are here:
Chat with us!